Commit To Buy Regeneron Pharmaceuticals At $320, Earn 6.6% Using Options
October 07, 2015 at 11:39 AM EDT
Investors considering a purchase of Regeneron Pharmaceuticals, Inc. (REGN) stock, but cautious about paying the going market price of $469.90/share, might benefit from considering selling puts among the alternative strategies at their disposal..